Spring blossoms and autumn fruits have arrived once again, forging ahead and continuing a new chapter. On January 27, 2024, Shandong Xinbo Pharmaceutical Research Co., Ltd. (hereinafter referred to as "Shandong Xinbo") held its 2024 academic committee meeting in the company's conference room.

Academic Commendation

The meeting was chaired by Chairman Liu Wenqian, who first commended the employees who actively carried out academic activities and achieved results in 2023, and hoped that the employees who received rewards would continue to work hard.

Academic Reports

The Academic Committee invited Dr. Zhang Yusheng, Deputy Director of the Science and Technology Department of Shandong University, to give a presentation titled "Strategies and Focus Points for Scientific Research Projects". Provide professional guidance on topic selection, project proposal, and application writing. At the same time, analyze the success of project applications in recent years, and encourage Xinbo colleagues that although the road is long, the journey is approaching; Although things are difficult, they must be done.

Liu Baofeng, Senior Vice President and Deputy Director of the Center, analyzed the positioning and prospects of Shandong Xinbo in China's innovative drug research and development, providing a detailed introduction to the current status of the non clinical research industry, Shandong Xinbo's past performance, competitive advantages and disadvantages, as well as its future prospects. Through detailed introduction and analysis, the direction of Shandong Xinbo's work in 2024 has been clarified.

Professor Liu Zhaoping, Director of the Academic Committee, delivered a report titled "Conducting the Selection of Excellent Summary Reports for 2024".

Director Liu pointed out that the summary report is a scientific research product of the entire company, the most important scientific research achievement of Shandong Xinbo, and the crystallization of everyone's hard work. We not only need to achieve standardized testing and reliable results, but also need to make our products into brands and enhance their value. Especially in today's fiercely competitive market, we cannot be satisfied with the status quo and must have a stronger sense of responsibility and urgency. Director Liu analyzed in detail the significance of selecting excellent summary reports, the mechanism for improving the quality of summary reports, the requirements for selecting excellent summary reports, and the expectations for new challenges and opportunities.

The process of evaluation is also a process of urging and improving the summary report and related work, and under this driving force, promoting the company's innovation and various scientific research work, truly realizing the responsibility of Xinbo and all employees to take public health as their own responsibility, and reflecting the social value of being a technology worker.

2024 is the 14th year of development for Shandong Xinbo, and the task of our development in 2024 is arduous and heavy. In 2024, we are full of determination and passion, moving forward against the wind and creating a brilliant future for Shandong Xinbo.